B. Riley Securities Reiterates Buy on Radiopharm Theranostics, Raises Price Target to $16

Benzinga · 12/16/2025 15:10
B. Riley Securities analyst Yuan Zhi reiterates Radiopharm Theranostics (NASDAQ:RADX) with a Buy and raises the price target from $13 to $16.